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Studies on the effects of garlic (Allium sativum) on hyperlipidemia have demonstrated somewhat contro-
versial results and there have been few studies on its enzymatic mechanism. The purpose of this study
was to assess the effect of garlic on the liver phosphatidate phosphohydrolase (PAP) activity, plasma lipid
levels, malondialdehyde (MDA) and plasma antioxidant in rats fed either by normal or high-lipogenic diet
with or without garlic. Male Wistar rats were fed by standard pellet diet (group I), standard diet supple-
mented with 4% garlic (group II), lipogenic diet (containing sunﬂower oil, cholesterol and ethanol) plus
4% garlic (group III) and only lipogenic diet (group IV). Results showed that garlic signiﬁcantly reduced
total cholesterol (TC), plasma triglyceride (TG), LDL-C, VLDL-C, liver triglyceride, plasma malondialdehyde
(MDA) and elevated plasma antioxidant in garlic treated rats (groups II and III) compared to group IV
(lipogenic diet group). Also, liver PAP activity was decreased in group II than group I whereas, the
decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver. Therefore,
the results are clearly indicative of the beneﬁcial effects of garlic in reducing lateral side effects of
hyperlipidemia.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Garlic (Allium sativum L.) and its compounds have been reported
to have diverse biological activities such as regulating plasma lipid
levels, anticarcinogenic, lead and mercury detoxiﬁcation, anti-
thrombotic, antibacterial, antioxidant, antihypertensive, antidia-
betic, and various other biological actions (Abdalla et al., 2009;
Agarwal, 1996; Azuma et al., 2007; Lau, 2006; Sharma et al., 2010).
Phosphatidate phosphohydrolase (PAP, EC 3.1.3.4) catalyzes the
dephosphorylation of phosphatidic acid to yield inorganic phos-
phate (Pi) and 1,2 diacylglycerol (Carman and Han, 2006). This en-
zyme plays a critical role in controlling the synthesis of
glycerophospholipids and triacylglycerols (Roberts et al., 1998).
The produced diacylglycerol serves as a precursor for the synthesis
of major glycerolipids in animal cells (Kanoh et al., 1992). This
reaction is a regulatory step in the synthesis of triacylglycerol
and phospholipids (Fleming and Yeaman, 1995). Additionally,
triglyceride (TG) serves as the major energy storage molecule that
allows organisms to survive periods of food deprivation. Also, the
regulation of TG storage is very important in human diseases
because both excessive and inadequate fat storage are accompa-
nied with dyslipidemia, insulin resistance, and diabetes (Hegelell rights reserved.
: +98 381 3346721.
rian).and Pollex, 2005; Petersen and Shulman, 2006; Reue and Phan,
2006). In rat hepatocyte, two different forms of PAP have been re-
ported based on N-ethylmaleimide (NEM) sensitivity (Heidarian
and Haghighi, 2008; Nanjundan and Possmayer, 2003; Fleming
and Yeaman, 1995). The NEM-sensitive form (PAP1), located in
cytosolic and microsomal fractions, requires Mg2+ for its activity
and is responsible for the synthesis of phospholipids and triacyl-
glycerols (Dillon et al., 1997). The other form of phosphatidate
phosphohydrolase (PAP2) is primarily involved in lipid signaling
pathways by modulating the second messengers of diacylglycerol
and phosphatidic acid (Brindley, 2004; Sciorra and Morris, 2002).
The incidence of hyperlipidemia as well as its complications is
increasing in the world. Moreover, alterations in serum lipid and
lipoprotein levels result in a variety of chronic diseases such as cor-
onary heart diseases and atherosclerosis (McKenney, 2001). Recent
studies have directed their efforts toward the protective effects of
plants such as garlic on hyperlipidemia (Ortega et al., 2007;
Mahmoodi et al., 2006; Gorinstein et al., 2006). Most of the previ-
ous studies on garlic have shown that garlic has cholesterol and tri-
glyceride-lowering effects (Singh and Porter, 2006; Sumioka et al.,
2006). Some researches have shown the reducing effect of garlic on
HMG-CoA reductase in the cholesterol biosynthesis pathway
(Gebhardt, 1991; Gebhardt and Beck, 1996). Also another study
indicated that garlic reduced incorporation of label glycerol into
the phospholipids biosynthesis (Yeh and Yeh, 1994). Nevertheless,
Table 1
The speciﬁc activity of PAP (nmol Pi/min/mg protein) and liver triglyceride content in
experimental groups.
Groups PAP activity
(nmol Pi/min/mg protein)
Liver triglyceride
(mg/g tissue)
I (control) 9.41 ± 0.39 3.80 ± 0.39
II 6.46 ± 0.62* 3.01 ± 0.65
III 8.52 ± 0.90** 6.31 ± 0.44**
IV 6.73 ± 0.27 7.38 ± 0.52
The data were expressed as mean ± S.D, n = 6 in each group. Normal diet (I); normal
diet supplemented with 4% garlic (II); hyperlipidemic rats treated with 4% garlic
(III); hyperlipidemic rats without treatment (IV) groups.
* P < 0.001 compared with the corresponding value for group I (normal control
animals).
** P < 0.001 compared with the corresponding value for group IV (lipogenic
regime).
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involving in triglyceride metabolism, especially PAP enzyme, in de-
tails. Garlic has many organosulfur compounds (Iciek et al., 2009)
which may work synergistically whereas a single component of
the garlic may not possess these properties. Therefore, the aim of
this study was to examine the medicinal uses of garlic on the liver
phosphatidate phosphohydrolase activity, plasma lipid levels, and
liver triglyceride in rats fed on high lipogenic and normal diet.
2. Materials and methods
2.1. Chemicals
Phosphatidic acid (sodium salts), 2,4,6-tripyridyl-s-triazine (TPTZ), phenylm-
ethylsulfunyl ﬂuoride (PMSF) and dithiothreitol (DTT) were purchased from Sigma
(Sigma Chemical Co., USA). Sodium tetraborate, bovine serum albumin, Tris–HCl,
sodium acetate, ferrous sulphate (FeSO47H2O), glacial acetic acid, ferric chloride
(FeCl36H2O), ethylenediaminetetra acetic acid (EDTA) and ethyleneglycol-bis
(beta-aminoethyl ether)-N,N,N0 ,N0-tetraacetic acid (EGTA) were purchased from
Merck (Germany). All other chemicals were of the highest quality available.
2.2. Preparation of garlic
Cloves of fresh garlic were purchased from the local supermarket. The garlic
was identiﬁed by Dr. Zainali in Isfahan Agricultural Research Center (Iran) as a local
variety. Every day peeled garlic cloves were crushed mechanically in a mortar–pes-
tle for 1 min. Then, the 4% garlic pellets were made by mixing 4 g of fresh crushed
garlic with 96 g of powdered standard rat pellet diet.
2.3. Animals and experimental design
Male Wistar rats (150–200 g) were housed in the colony room on a cycle of 12 h
light/12 h darkness at 21 ± 2 C and had free access to water and food. They were
randomly divided into 4 diet groups (n = 6/group) as below:
Group I, normal control rats, received standard pellet diet.
Group II, animal rats were fed with a standard pellet diet supplemented with 4%
garlic.
Groups III and IV, the rats were fed with a lipogenic diet containing standard
pellet diet supplemented with 0.5% (w/w) cholic acid, 20% (w/w) sunﬂower oil
and 2% (w/w) cholesterol for at least two weeks to produce hyperlipidemia. Addi-
tionally, groups III and IV drank water containing 3% (v/v) ethanol (Yanardag
et al., 2005). In group III, after 2 weeks, 4% (w/w) garlic was added into lipogenic re-
gime for 45 days, whereas the rats in group IV were maintained on lipogenic diet.
On d 60 of the experiment, fasted animals anesthetized with chloroform. Blood
samples were collected into test tubes containing EDTA through cardiac puncture.
The plasma samples were separated by low speed centrifugation (2000g) for 10 min
and were stored at 80 C until they were analyzed. All animal procedures were
performed with regard to Iranian animal ethics society and local university rules.
2.4. Analytical procedures
Plasma levels of total cholesterol (TC), triglyceride (TG) and HDL-C were deter-
mined by enzymatic method (Pars Azmun kit, Iran) with JENWAY spectrophotom-
eter (model 6105, England). LDL-C and VDL-C concentrations were calculated with
Fridewald formula (Friedewald et al., 1972). Finally, liver triglyceride was extracted
from liver tissue by Folch-altered method invented by Norman (1969).
2.5. Preparation of rat liver
The rat liver was perfused through the inferior vena cava with ice-cold saline
(0.9%) to remove blood and inorganic phosphate from it to evaluate liver PAP activ-
ity and liver triglyceride. A part of perfused liver was homogenized in 4 volumes of
ice-cold buffer A (0.25 M sucrose, 0.1 mM EDTA, 1 mM PMSF, pH 7.4) (Haghighi and
Honarjou, 1987) using homogenizer (Heidolph, Silentcrusher Mmodel, Germany) at
8000 rpm at 4 C for 6 min. The homogenate was then initially centrifuged at
4500 rpm at 4 C for 10 min, resulting in a nuclear pellet and then, the supernatant
kept for the enzyme assay.
2.6. Enzyme assay
PAP activity was measured in the assay buffer (250 ll) containing 50 mM Tris
HCl buffer pH 7.4, 1 mM DTT, 1 mM EGTA, 2 mM MgCl2, 1 mM EDTA, 0.35 mM
phosphatidate and appropriate amount of the enzyme solution. The assay mixture
incubated for 30 min at 37 C. The reaction stopped by adding 0.5 ml trichloroacetic
acid (10%). Hence, the released Pi measured (Haghighi and Honarjou, 1987). All as-says were linear in relation to the incubation time and the protein concentrations
used in them. One unit (U) of PAP activity deﬁned as the amount of enzyme that
catalyzes the release of 1 lmol of Pi per min under the standard assay conditions.
Speciﬁc activity was considered as units per mg protein. Protein concentration
was determined by the method of Bradford (1976), with bovine serum albumin
as the standard.
2.7. Measurement of malondialdehyde
The plasma malondialdehyde (MDA) level was measured by the thiobarbituric
acid reactive substances (TBARS) method as described by Ohkawa et al. (1979). The
measurements were done in duplicates and the results were expressed in lM. MDA
standards were prepared from 1,1,3,3-tetraethoxypropane (TEP).
2.8. Antioxidant power assay
The antioxidant power of plasma was determined by measuring its ability to
reduce Fe3+ to Fe2+ with FRAP (ferric reducing/antioxidant power) test (Benzie
and Strain, 1996). FeSO4 was used as a standard of FRAP assay at a concentration
range between 100 up to 1000 lM. The results are expressed as lM.
2.9. Statistical analysis
The data were expressed as mean ± S.D. They were analyzed by SPSS software
(version 11.5). For statistical analysis of the data, group means were compared by
one-way analysis of variance (ANOVA) followed by Tukey post hoc test for multiple
comparison. Differences were considered signiﬁcant at P < 0.05 level.
3. Results
3.1. Effect of garlic on the liver triglyceride and PAP activity
Table 1 summarizes the effect of garlic on the liver triglyceride
and PAP activity. Group II had a signiﬁcant decrease (P < 0.001) in
the liver PAP activity compared to group I whereas, no remarkable
change was observed in liver PAP activity between group II and
group IV (P > 0.05). Group IV showed a signiﬁcant increase
(P < 0.001) in the liver triglyceride compared with other groups.
Also, the liver triglyceride in group II was slightly lowered com-
pared with group I (not signiﬁcant, P > 0.05). The liver triglyceride
in group III was signiﬁcantly declined (P < 0.001) with respect to
group IV.
3.2. Effect of garlic on plasma level of hyperlipidemia
Table 2 shows the mean plasma levels of TG, TC, VLDL-C, LDL-C,
HDL-C and atherogenic index in control and treated animals with
garlic in each group. The levels of plasma TG, TC, VLDL-C, and
LDL-C in group IV (consuming oil and cholesterol diet) were signif-
icantly elevated (P < 0.05) compared to other groups. Additionally,
the level of plasma TG in group III showed no salient difference
compared to group I (P > 0.05). Plasma TG showed a noticeable dif-
ference (P < 0.001) between groups I and II. In group IV, the plasma
Table 2
Effect of garlic on TC, TG, LDL-C, HDL-C, VLDL-C levels and atherogenic index in hyperlipidemic rats.
Groups TC (mg/dl) TG (mg/dl) LDL-C (mg/dl) HDL-C (mg/dl) VLDL-C (mg/dl) Atherogenic index (units)
TC/HDL-C LDL/HDL-C
I 87.71 ± 13.61 55.98 ± 9.22 23.52 ± 2.07 51.67 ± 5.39 10.50 ± 2.43 1.70 ± 0.16 0.47 ± 0.13
II 79.17 ± 4.62 40.82 ± 8.65* 24.06 ± 1.02 47.10 ± 5.22 8.17 ± 0.91* 1.73 ± 0.12 0.58 ± 0.09
III 119.40 ± 15.67** 56.01 ± 6.31** 54.77 ± 5.62** 57.96 ± 7.18 11.24 ± 1.25** 2.27 ± 0.07 1.01 ± 0.11
IV 142.25 ± 29.93# 75.56 ± 4.77# 70.67 ± 10.81# 58.41 ± 8.72# 15.11 ± 0.95# 2.42 ± 0.26# 1.21 ± 0.23#
The data are expressed in mean ± S.D, n = 6 in each group. Normal diet (I); normal diet supplemented with 4% garlic (II); hyperlipidemic rats treated with 4% garlic (III);
hyperlipidemic rats without treatment (IV) groups.
* P < 0.001 compared with the corresponding value for group I (normal control animals).
** P < 0.001 compared with the corresponding value for group IV (lipogenic regime).
# P < 0.001 compared with the corresponding value for groups I and II.
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groups I, II and III. On the other hand, the plasma level of TC in the
rats which consume standard diet supplemented with garlic
(group II) was lower than group I (control group) but not signiﬁ-
cant (P > 0.05). In group III, LDL-C were remarkably (P < 0.05) high-
er than groups I, II and IV. Moreover, no signiﬁcant difference
(P > 0.05) was seen for LDL-C between groups I and II. HDL-C re-
duce slightly in group II compared to group I (not signiﬁcant,
P > 0.05). VLDL-C signiﬁcantly decreased (P < 0.001) in groups II
and III compared to groups I (control group) and IV, respectively.
There was a reduction (not signiﬁcant, P > 0.05) in atherogenic in-
dex in group III compared with group IV (Table 2). In added, no
salient change was seen in atherogenic index between groups I
and II.3.3. Effect of garlic on the plasma level of malondialdehyde
Fig. 1 shows that after the consumption of lipogenic diet, a sig-
niﬁcant (P < 0.001) increase in plasma malondialdehyde was ob-
served in group IV (the group consumed oil and cholesterol diet)
when compared with other groups. On the other hand, in group
II the consumption of garlic led to an important (P < 0.05) reduc-
tion of plasma malondialdehyde in comparison with group I (con-
trol group). Also, a signiﬁcant (P < 0.001) reduction of plasma
malondialdehyde was seen in group III, fed with a lipogenic diet
supplemented with garlic, as compared with group IV.Fig. 1. Plasma malondialdehyde level in normal diet (I); normal diet supplemented
with 4% garlic (II); hyperlipidemic rats treated with 4% garlic (III); hyperlipidemic
rats without treatment (IV) groups. The data are expressed as mean ± S.D, n = 6 in
each group. #P < 0.001 compared with the corresponding value for normal control
animals. ⁄P < 0.001 compared with the corresponding value for hyperlipidemic rats
without treatment.3.4. Effect of garlic on the plasma level of antioxidant power
Fig. 2 shows the plasma level antioxidant power in each exper-
imental animal group. Garlic treatment resulted in a signiﬁcant
(P < 0.001) elevation of plasma level antioxidant power in group
II as compared to the other groups. There was a signiﬁcant
(P < 0.001) reduction in plasma level antioxidant power in groups
III and IV. No signiﬁcant change was observed in plasma level anti-
oxidant power between groups III and I (P > 0.05).4. Discussion
The consumption of excessive calories by human, leads to high
serum TG. On the other hand, increased levels of serum low-
density lipoprotein cholesterol (LDL-C) and TG show that the diet
containing fatty acids and cholesterol leads to hypercholesterol-
emia (Hegsted et al., 1965). Fruit and vegetables have chemopre-
ventive and ﬂavoring agents which act against various diseases
especially hyperlipidemia (Ortega et al., 2007). Experimental stud-
ies in recent years have indicated that garlic has cholesterol and
triglyceride-lowering, antibacterial, hypoglycemic, hypotensive
potential and antiaggregatory properties (Agarwal, 1996; Aviello
et al., 2009; Azuma et al., 2007; Gorinstein et al., 2007). The effects
of garlic on serum lipid levels have been investigated in human and
animal models and indicate inconsistency in the reported resultsFig. 2. Plasma antioxidant capacity (FRAP) in normal diet (I); normal diet
supplemented with 4% garlic (II); hyperlipidemic rats treated with 4% garlic (III);
hyperlipidemic rats without treatment (IV) groups. The data are expressed as
mean ± S.D, n = 6 in each group. #P < 0.001 compared with the corresponding value
for normal control animals. ⁄P < 0.001 compared with the corresponding value for
hyperlipidemic rats without treatment.
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triacylglycerol lowering action of garlic, we measured liver triglyc-
eride content and the liver PAP enzyme activity involving in TG
biosynthesis. Our data have shown that 4% garlic supplementation
in hyperlipidemic rats was highly effective in reducing serum
cholesterol and TG levels as compared to the high cholesterol diet
and control diet group of animals (Table 2). The same results were
obtained by other investigators (Singh and Porter, 2006; Sumioka
et al., 2006). Also, it has been reported that methanol and water
extractable fractions of fresh garlic prevented the 114C-acetate
incorporation into the biosynthesis of cholesterol and depressed
the rate of [2–3H] glycerol incorporation into the biosynthesis of tri-
acylglycerol, diacylglycerol and phospholipids (Yeh and Yeh, 1994).
The above published works do not assess the effect of garlic on PAP
activity. In our study however, the garlic supplementation resulted
in higher reduction of PAP activity in group II than group I (control
group) (Table 1). Therefore, the serum and liver triglyceride reduc-
tion in group II are due to decline of the liver PAP activity (Tables 1
and 2). Allicin (diallyl disulﬁde), an active constituent of garlic, has
been reported to lower the serum lipid proﬁle in hyperlipidemic
rabbits (Eilat et al., 1995). In another study cycloalliin, a sulfur imi-
no acid compound with a cyclic structure found in onions, mark-
edly reduced serum TG concentration in rats without signiﬁcant
alteration on liver PAP activity and hepatic triglyceride content
(Yanagita et al., 2003). This result in PAP activity contradicts our
study which can be due to the composition of garlic in this study.
Garlic contains more than 30 biological organosulfur agents such
as diallyl trisulﬁde, diallyl disulﬁde and diallyl sulﬁde (Amagase
et al., 2001; Iciek et al., 2009).These agents may work synergisti-
cally to reduce liver PAP activity and exhibit various biological
activities which a single component such as cycloalliin may not
be able to do. On the other hand, in lipidemic groups liver PAP
activity also declined with respect to control group but, their liver
triglyceride concentration increased in this study (Table 1). It has
been reported that excessive intake of fatty acids leads to an accu-
mulation of TG in many tissues, particularly in fat tissue and non-
adipose tissues such as liver (Lebovitz, 2001). Also, it was shown
that fatty acid esters promote the inactivation of PAP (Elabbadi
et al., 2005). Fatty acids and their acyl-CoA esters regulate PAP
by a negative allosteric interaction, leading to the formation of
inactive PAP fatty acids (or -acyl-CoA esters) complex (Elabbadi
et al., 2005). Therefore, the reduction of liver PAP activity in this
study in groups fed with high lipid regime (groups III and IV) is
due to the accumulation of triglyceride (Table 1), fatty acids or
acyl-CoA esters in the liver. On the other hand, liver PAP reduction
activity in groups fed with high lipid regime (groups II and III) can
probably be due to the defense mechanism of liver in lowering the
production of endogenous TG. Therefore, serum and liver TG will
accordingly decline. Besides, in this study liver fat content signiﬁ-
cantly increased in animal groups fed by lipogenic regime (groups
III and IV) with respect to the group I (control group). Garlic re-
sulted in slight decrease in liver triglyceride in group fed by garlic
(group II) compared with the control animals (group I). These re-
sults were consistent with the reduction of PAP activity in group
II. In contrast, groups fed by lipogenic regime (groups III and IV)
had high TG content in the liver as compared to the normal control
animals (group I).
Studies on cell lines and animal models have shown that allicin
also inhibit the HMG-CoA reductase level in the cholesterol biosyn-
thesis pathway (Gebhardt, 1991; Gebhardt and Beck, 1996). In this
study, garlic supplementation resulted in signiﬁcant reduction of
cholesterol in group III when compared to group IV (lipemic
regime group). However, garlic supplementation reduced TC in
group II as opposed to group I but the difference was not signiﬁcant
(Table 2). Our ﬁndings were in line with other investigators
who reported that garlic consumption decreased serum totalcholesterol and TG but increased HDL cholesterol in hyperlipi-
demic individuals and animals (Gorinstein et al., 2006; Mahmoodi
et al., 2006; Thomson et al., 2006).
Previous studies have reported the antioxidant effect of garlic
(Durak et al., 2004; Gorinstein et al., 2006). Oxidative stress dis-
rupts the equilibrium between prooxidants and antioxidants in
biological systems and leads to lipid peroxidation (LPO) and free
radical generation (Romero et al., 1998). The level of malondialde-
hyde (MDA) is considered as a biomarker of LPO (Lykkesfeldt,
2007). Garlic extracts increase superoxide dismutase (SOD) and
catalase (CAT) activities in vascular cultured cells. S-allylcysteine
sulfoxide (alliin), a bioactive compound of garlic, prevents the
reduction of hepatic SOD and CAT activities in diabetic rats
(Gorinstein et al., 2006). Also, it has been reported that garlic sig-
niﬁcantly lowers plasma and erythrocyte MDA levels while
increasing antioxidant enzyme activity in elderly subjects (Avci
et al., 2008). In the present study, plasma MDA signiﬁcantly in-
creased in hyperlipidemic animals whereas, antioxidant power of
plasma declined. Garlic supplementation potentially resulted in
signiﬁcant elevation of plasma antioxidant power and decreased
plasma MDA level in treated rats (Figs. 1 and 2), suggesting that
garlic might have antioxidant activities to produce such responses.
In this respect, there are published reports concordant with our re-
sults (Durak et al., 2004; Gorinstein et al., 2006). The antioxidant
potential of garlic is due to its organosulfur, alliin, and nonsulfur
components such as N-fructosyl-arginine and N-fructosyl-gluta-
mate which were shown to have antioxidant activity (Amagase
et al., 2001; Ryu et al., 2001). Therefore, the garlic supplementation
used in our study appears to lower oxidative stress related to
hyperlipidemic regime and to decrease lipid oxidation.
The ﬁndings of this work shows garlic has beneﬁcial effects in
reducing liver triglyceride, plasma MDA and liver PAP activity.
Also, garlic is useful in the control of hyperlipidemia, abnormalities
in lipid proﬁles and oxidative stress in hyperlipidemic regime
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